SciSparc Ltd.
SciSparc Ltd. (NASDAQ: SPRC) is trading at $5.24, about ₹503 at today's USD/INR rate, as of 25 Sep 2026, 10:48 AM ET, down 2.78% today. Indian residents can buy SciSparc from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
$5.21
Today's high
$5.32
52 week low
$2.98
52 week high
$63.90
SPRC opened at $5.28, closed previously at $5.39, and has traded between $2.98 and $63.90 over the past 52 weeks.
About
SciSparc Ltd. is a pharmaceutical company in the clinical development phase, specializing in creating medications derived from cannabinoid molecules. Their therapeutic pipeline encompasses several key drug candidates: SCI-110, which is being investigated for the treatment of Tourette syndrome, obstructive sleep apnea, and agitation associated with Alzheimer's disease; SCI-160, designed to address pain; and SCI-210, targeting autism spectrum disorder and epilepsy. The company has formed strategic alliances to further its goals. A partnership with Procaps focuses on the development and eventual commercial manufacturing of SCI-110, as well as CannAmide, an oral palmitoylethanolamide in a soft gel capsule. SciSparc is also collaborating with the Sheba Fund for Health Services and Research to explore SCI-210's potential in managing status epilepticus. Additionally, it has teamed up with The Israeli Medical Center for Alzheimer's to conduct a Phase IIa clinical trial, evaluating the safety, tolerability, and effectiveness of SCI-110 for patients experiencing Alzheimer's disease and agitation. Founded in 2004, the company initially operated under the name Therapix Biosciences Ltd. before changing to SciSparc Ltd. in January 2021. Its main corporate office is located in Tel Aviv-Yafo, Israel.
Key statistics
Avg. volume
829.01K
Market cap
$303.08K
P/E Ratio
-0.02
Price-to-sales ratio
0.35
Enterprise value
-$3.92M
Free cash flow yield
-1365.00%
Debt-to-equity ratio
0.09
Return on equity
-704.60%
ROIC
-152.55%
Beta
2.44
Dividend yield
0.00%
Last dividend
$0.00
Financial overview
Revenue
$856.00K
Earnings per share
-$882.64
Free cash flow
-$4.14M
Net profit margin
-1422.78%
Gross margin
46.38%
EBITDA
-$12.32M
Revenue growth
-34.46%
Similar securities
This is not an investment recommendation
How to buy SciSparc from India
Indian residents can buy SciSparc shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.
Search for SciSparc and place an order
Find SciSparc by name or by its ticker, SPRC, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. SciSparc trades 7:00 pm – 1:30 am IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your SciSparc position in USD and INR. SciSparc pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in SciSparc from India
Trading and taxes when buying SciSparc from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm ET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneSciSparc does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
FAQs
Can Indian residents buy SciSparc stock?
Yes. SciSparc (SPRC) has been listed on NASDAQ since 2021, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
How much does one SciSparc share cost in rupees?
One SciSparc share is $5.24 — about ₹503 at a USD/INR rate of 96.02 on 24 Sep 2026. Both the SciSparc price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying SciSparc from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
Can I buy whole shares of SciSparc?
Yes. One SciSparc share is $5.24, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in SciSparc.
How are gains on SciSparc shares taxed in India?
The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the SciSparc price. Paasa issues a capital-gains statement for your return.
Does SciSparc pay a dividend?
No. SciSparc does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade SciSparc from India?
NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.
Is SciSparc a United States company, and does that change how it is taxed?
SciSparc trades on NASDAQ in US dollars, but the company is domiciled in Israel. SciSparc trades as an ordinary share listed directly in the US, not a depositary receipt. Some non-US companies list in the US through American Depositary Receipts, which can carry dividend withholding at the company's home-country rate. Your India-side capital-gains treatment is the same either way.
Do I have to declare SciSparc shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your SciSparc holding, its cost and its closing value.
How do I sell SciSparc and bring the money back to India?
You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.